LEUKEMIA, LYMPHOCYTIC, ACUTE
Clinical trials for LEUKEMIA, LYMPHOCYTIC, ACUTE explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, LYMPHOCYTIC, ACUTE trials appear
Sign up with your email to follow new studies for LEUKEMIA, LYMPHOCYTIC, ACUTE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Supercharging your own immune cells to fight blood cancer
Disease control Recruiting nowThis early-phase study tests a personalized treatment for people with certain blood cancers, like leukemia. Researchers take a patient's own immune cells (T cells), modify them in a lab to recognize unique markers on their cancer cells, and then infuse them back. The goal is to s…
Matched conditions: LEUKEMIA, LYMPHOCYTIC, ACUTE
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 11:49 UTC
-
New hope for leukemia patients: experimental drug enzomenib enters human trials
Disease control Recruiting nowThis study tests an experimental drug, enzomenib, in people with acute leukemia and other blood cancers that have not responded to standard treatments. The goal is to find a safe dose and see if the drug can shrink or control the cancer. About 600 participants will take part in t…
Matched conditions: LEUKEMIA, LYMPHOCYTIC, ACUTE
Phase: PHASE1, PHASE2 • Sponsor: Sumitomo Pharma America, Inc. • Aim: Disease control
Last updated May 20, 2026 11:53 UTC